K131565

Substantially Equivalent

XTAG CYP2C19 KIT V3

Applicant: Luminex Molecular Diagnostics, Inc.
Product code: NTI
Advisory panel: Clinical Toxicology
Date received: 2013-05-30
Decision date: 2013-09-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Toronto, Ontario, CA

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.